2022 annual financial data
Greenwich LifeSciences 2022 Net income growth
Direct answer
Net income growth was -71.21%.
Operating income was -8,040,254 USD and net income was -7,825,237 USD.
Operating cash flow was -6,200,027 USD.
Get free Greenwich LifeSciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -8,040,254 USD
- Net income
- -7,825,237 USD
- Operating cash flow
- -6,200,027 USD